Mirati appoints EVP and chief business officer
Prior to joining Mirati, Mr. LeMasters served as the CEO of Promosome, a privately held biotherapeutics and biosimilars company.
Previously, Mr. LeMasters held senior management positions at several biotherapeutics companies, most recently as co-founder and chief business officer of Tragara Pharmaceuticals, a clinical-stage cancer therapeutics company.
Mr. LeMasters also served as co-founder and chief business officer of Cabrellis Pharmaceuticals, Inc., where he negotiated its acquisition by Pharmion Corporation, and as vice president, corporate development of Conforma Therapeutics, where he negotiated its acquisition by Biogen IDEC.
Mr. LeMasters also worked in the corporate business development group at Eli Lilly & Company and was responsible for the successful negotiation of numerous partnerships and licenses across a range of therapeutic areas.
Earlier in his career, he was a management consultant with Coopers & Lybrand Consulting and an operational auditor with Owens Corning.
Mr. LeMasters currently serves as a board member of Aarden Pharmaceuticals, where he is also a co-founder, and as a board member of the Hoosier Cancer Research Network, a clinical research organization. ■
LATEST MOVES FROM California
- NuVasive appoints Rajesh J. Asarpota as CFO
- Sanmina appoints David Anderson as CFO
- RPX Corporation appoints Marty Roberts to board
- Pfenex appoints Evert Schimmelpennink as CEO
- Aqua Metals appoints Mark Weinswig as CFO
More inside POST
Things successful leaders did only once Leadership